UPDATE 1-Roche receives blood cancer drug blow after Gazyva trial fails to meet endpoint - Reuters

Channel NewsAsia

UPDATE 1-Roche receives blood cancer drug blow after Gazyva trial fails to meet endpoint Reuters (Adds background, detail). ZURICH, July 18 Swiss drugmaker Roche said trials showed its new blood cancer drug Gazyva failed to deliver significant improvements over an older medicine in people with an aggressive type of blood cancer, a blow in its ... Roche says Gazyva does not meet primary endpoint in phase III testingKFGO all 3 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNF45zFZ-qw427ln5GWmYlnJ37AwVg&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779161887323&ei=iXuMV_iNGILf3AG4wpAQ&url=http://www.reuters.com/article/roche-gazyva-idUSL8N1A40KQ
via IFTTT